Correction: DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity

Bin Chen, Feng Xu, Yang Gao, Guanshuo Hu, Kaili Zhu, Huayi Lü, An Xu, Shaopeng Chen, Lijun Wu, Guoping ZhaoOncogene 2025 · DOI · OpenAlex

Introduction

This article serves as a formal correction to a 2022 study published in Oncogene regarding the protein HIGD1A. The authors identified an assembly error in a representative image within Figure 7e. Following a retrospective audit of the original experimental data, the authors have replaced the incorrect panel, confirming that the study's original conclusions—that HIGD1A translocates from the mitochondria to the nucleus to facilitate DNA repair—remain scientifically robust and unchanged.

The Problem: Maintaining Scientific Integrity

In complex biological research involving multi-panel figures, errors can occasionally occur during final assembly. This correction addresses such an instance, ensuring the visual evidence accurately reflects the underlying data. The original research explored a critical "moonlighting" function of HIGD1A, a protein typically localized to the mitochondria. The study demonstrated that in response to DNA damage, HIGD1A moves to the nucleus to regulate homologous recombination, a high-fidelity DNA repair mechanism. This process directly influences the sensitivity of cancer cells to chemotherapy and radiation.

Methods and Experimental Design

The original study employed a variety of molecular biology techniques across multiple human cancer cell lines, including HCT116 (colorectal), HeLa (cervical), MCF7 (breast), and A549 (lung). Key methods included:

  • RNA Interference (shRNA): Used to knock down HIGD1A expression to observe the effects of its absence.
  • Adenoviral Overexpression (adHIGD1A): Used to increase HIGD1A levels and observe the effects of its abundance.
  • Cell Viability Assays: Measuring the survival of cancer cells treated with DNA-damaging agents like Cisplatin and Etoposide.
  • Western Blotting and Flow Cytometry: To track DNA damage markers (e.g., $\gamma$H2AX) and analyze cell cycle distribution.

Key Insights: The Mitochondria-to-Nucleus Axis

The research highlights a novel signaling axis where HIGD1A acts as a sensor for genomic stress. When DNA damage occurs, HIGD1A translocates to the nucleus, where it aids in repair. This mechanism has significant clinical implications for chemo-sensitivity.

Impact of HIGD1A Knockdown

Experimental data showed that reducing HIGD1A levels makes cancer cells more vulnerable to treatment. For instance, in MCF7 breast cancer cells, the knockdown of HIGD1A (shHIGD1A) significantly decreased cell viability when exposed to increasing doses of Cisplatin compared to non-targeting (NT) controls.

Figure 1: HIGD1A knockdown (shHIGD1A) increases the sensitivity of MCF7 breast cancer cells to Cisplatin treatment compared to control (NT shRNA).

Impact of HIGD1A Overexpression

Conversely, increasing HIGD1A levels can enhance the cell's ability to survive DNA damage. In H28 lung cancer cells, the overexpression of HIGD1A (adHIGD1A) resulted in higher cell viability following Cisplatin treatment compared to cells transfected with an empty vector. This suggests that high levels of HIGD1A may contribute to treatment resistance in certain tumors.

Figure 4: Overexpression of HIGD1A (adHIGD1A) enhances the survival of H28 lung cancer cells treated with Cisplatin compared to vector controls.

Conclusion and Future Directions

While the correction rectifies a visual assembly error, the fundamental discovery of the HIGD1A-mediated DNA damage response remains intact. The study suggests that targeting the nuclear translocation of HIGD1A could be a viable strategy to sensitize resistant tumors to existing therapies. Future research will likely focus on identifying the specific transport mechanisms that facilitate HIGD1A's movement between cellular compartments.

Summary updated

BibTeX
@inproceedings{chen2025correction,
  author = {BIN CHEN and Feng Xu and Yang Gao and Guanshuo Hu and Kaili Zhu and Huayi Lü and An Xu and Shaopeng Chen and Lijun Wu and Guoping Zhao},
  title = {{Correction: DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio/chemo-sensitivity}},
  booktitle = {Oncogene},
  year = {2025},
  doi = {10.1038/s41388-025-03438-5},
}
Figure